Weight Loss Journey
60 articles on Weight Loss Journey, researched and written by the Shotlee Editorial Team from primary sources.
Ozempic Lowers Calorie Intake For At Least A Year, Even If Hunger Returns, Trial Finds
A new 60-week clinical trial reveals that semaglutide continues to reduce calorie consumption significantly, even when subjective hunger sensations return to baseline levels.
7 min read
Millions Losing Weight Using GLP-1s: How Do Drugs Affect Love Lives?
As millions turn to GLP-1 medications for weight loss, unexpected changes in romantic relationships and sexual desire are emerging. This article explores the psychological and physiological impacts on love lives.
6 min read
Rosie O'Donnell: Mounjaro Changed My Life After Losing 30kg
Talk show host Rosie O'Donnell discusses her 30kg weight loss using Mounjaro, the subsequent skin concerns, and the mental health benefits of GLP-1 therapy.
6 min read
Novo Nordisk Sues Eli Lilly Over Which GLP-1 Sheds the Most Pounds
Novo Nordisk has filed a federal lawsuit against Eli Lilly, alleging deceptive advertising regarding the comparative weight loss efficacy of Zepbound and Wegovy. The dispute centers on dosage comparisons and clinical trial data interpretation.
8 min read
Amy Schumer Shows Off Ongoing Weight Loss, Says C-Section Scar Makes Her a 'Warrior'
Comedian Amy Schumer discusses her 50-pound weight loss journey, Cushing syndrome diagnosis, and C-section recovery in a candid new update.
10 min read
Anandita Sundar's 7-Year Weight Loss Journey and Body Shaming
Anandita Sundar opens up about her seven-year weight loss journey, highlighting the profound impact of body shaming on mental health and her commitment to prioritizing well-being over societal expectations.
7 min read
Amy Schumer Highlights C-Section Scar After Weight Loss Journey: 'I'm a Warrior'
Amy Schumer, known for her candidness, recently shared a powerful image highlighting her C-section scar, a testament to her strength and resilience throughout her health and weight loss journey.
6 min read
Amy Schumer Reveals Ongoing Weight Loss in New Selfie, Says C-Section Scar Makes Her a 'Warrior'
Comedian Amy Schumer recently shared a selfie highlighting her weight loss and C-section scar, opening up about her diagnosis of Cushing's syndrome and her path to health.
7 min read
People Taking GLP-1 Weight Loss Drugs Like Ozempic and Wegovy Started Moving Less
New data presented at ENDO 2026 reveals a paradox: patients on GLP-1 medications like Ozempic and Wegovy reduced their physical activity despite losing weight.
8 min read
Wegovy Weight Loss Pill Warning: Make Three Changes Now
The new oral Wegovy formulation has arrived, but hair shedding concerns remain. Discover the science behind the risk and three actionable lifestyle changes to protect your hair health while on semaglutide.
8 min read
Managing Ozempic and Wegovy Weight Loss Side Effects: Nausea and Beyond
New research is shedding light on how GLP-1 medications, including popular drugs like Ozempic and Wegovy, influence brain pathways that control nausea, thirst, and reward-driven behaviors. This article delves into these findings and discusses potential strategies for managing common side effects.
7 min read
Beyond the Jab: A Natural Weight Loss Journey and Its Hidden Costs
Melanie Sivier chose the 'hard way' over bariatric surgery or new GLP-1 medications like Ozempic and Mounjaro, shedding nine dress sizes through dedication. Her story highlights the profound commitment required for sustainable change, and the often-overlooked physical aftermath.
6 min read
Ozempic, Wegovy & Mounjaro: What Your Bones & Joints Need to Know
Millions are experiencing significant weight loss with GLP-1 medications. But what happens to your bones, joints, and muscles as the pounds drop? An orthopedic surgeon shares crucial insights.
7 min read
Ozempic, Wegovy, Mounjaro: The GLP-1 Revolution in Weight Loss
A closer look at the groundbreaking GLP-1 medications, including Ozempic, Wegovy, and Mounjaro, and their transformative effects on weight management and overall health.
6 min read
Beyond the Jab: One Woman's Journey to 9-Stone Weight Loss
Melanie Sivier shares her remarkable 9-stone weight loss journey, opting for a dedicated lifestyle change over medical interventions like gastric bands and newer GLP-1 agonists.
6 min read
Beyond the Scale: Navigating GLP-1s for Older Adults
As GLP-1 medications become more accessible, older adults are asking: 'Am I too old?' This guide explores the nuances of using these powerful drugs for weight loss in seniors, emphasizing health over age.
7 min read
Wegovy and Ozempic: The Critical Question to Prevent Weight Regain
Discover the single most important question to ask before starting GLP-1 medications like Ozempic or Wegovy. Learn how to ensure sustainable weight loss and avoid the common pitfalls of viewing these drugs as a magic cure.
8 min read
Beyond the Scale: GLP-1 Users & the Exercise Paradox
While GLP-1 medications have revolutionized weight loss, a recent study indicates a concerning trend: users may be reducing their physical activity. This article explores the findings and emphasizes the continued importance of exercise.
7 min read
Wegovy, Ozempic & Mounjaro: The Real Truth About Weight Loss Meds
A comprehensive guide to GLP-1 receptor agonists, understanding efficacy, managing side effects, and navigating the future of obesity treatment.
7 min read
Alli's Kidney Risk: FDA Updates Label for Over-the-Counter Weight Loss Pill
The FDA has issued a critical update to the drug facts label for Alli, the only over-the-counter weight loss medication available in the U.S. The changes highlight rare but potentially severe kidney-related side effects, prompting new warnings for consumers.
7 min read
Wegovy, Zepbound & More: Hers Makes GLP-1s Accessible from $39
The journey to weight loss can be challenging, and for many, advanced medications like GLP-1 injectables offer a crucial pathway. However, their high cost often presents a significant barrier. Hers is changing this landscape by making popular GLP-1 and other weight loss treatments more accessible and affordable than ever before.
7 min read
Wegovy Pill Launch: Why 80% of Patients Are Choosing Oral Semaglutide
The launch of the Wegovy pill marks a pivotal shift in obesity treatment. With 80% of new users being first-time patients, oral semaglutide is overcoming historical barriers to care.
9 min read
Ozempic Muscle Loss: How a New Compound Preserves Strength
New research from Stanford Medicine reveals a potential solution to the muscle loss associated with GLP-1 medications like Ozempic and Wegovy, offering hope for stronger, healthier weight loss.
8 min read
Beyond the Needle: New Oral Semaglutide Tech Could Change Weight Loss Forever
Duke University researchers have developed a novel oral delivery system for GLP-1 medications that protects peptides from stomach acid, potentially eliminating the need for injections.
8 min read
Beyond the Scale: Unpacking the 'Darth Vader' Effect of Rapid Weight Loss
A peculiar new side effect, dubbed the 'Darth Vader' effect, is emerging with rapid weight loss achieved through GLP-1 medications. This article delves into the phenomenon, its potential causes, and the critical need for a balanced approach to weight management.
7 min read
Ozempic, Mounjaro & More: Bridging the Global Gap for Cheaper Biologics
While generics have revolutionized drug affordability, newer biologics like those used for weight loss and diabetes face unique challenges. A new study reveals how varying international regulations are slowing the adoption of affordable biosimilars, impacting patient access and costs.
6 min read
Ozempic, Mounjaro & Compounded GLP-1s: South Africa's Regulatory Crackdown
South Africa's regulatory bodies are taking decisive action against the booming market for compounded GLP-1 weight-loss drugs, including versions of Ozempic and Mounjaro. This crackdown highlights significant safety concerns and potential risks to public health.
8 min read
Semaglutide Plateaus: New Brain Discovery Could Boost Weight Loss Results
New research from the NIH reveals how semaglutide signaling in the brain affects weight loss plateaus, offering hope for improved efficacy and dosing strategies.
7 min read
Oral GLP-1s Enter the Ring: Early Trends Favoring Foundao Over Wegovy's Pill
The landscape of weight loss treatments is rapidly changing with the introduction of oral GLP-1 medications. This article delves into early adoption trends, comparing the initial uptake of Eli Lilly's oral semaglutide (Foundao) against Novo Nordisk's oral semaglutide (Wegovy's pill), and what these patterns signify for patients and physicians.
6 min read
Mounjaro, Wegovy & Hair Loss: Navigating the Side Effect and Regrowth
Rapid weight loss from GLP-1 medications can lead to temporary hair thinning. This article explores the causes of this common side effect and provides actionable advice for managing and encouraging hair regrowth, drawing on personal experiences and expert insights.
7 min read
Beyond the Hype: Understanding the 'GLP-1 Face' and Evolving Beauty Standards
The rise of GLP-1 medications is sparking conversations about beauty standards, with some experts predicting a shift towards a 'GLP-1 face' aesthetic. This article delves into the science, societal impact, and artistic implications of this evolving trend.
7 min read
Retatrutide Breakthrough: Can This Molecule Rival Gastric Bypass Surgery?
New data suggests Eli Lilly's retatrutide could deliver up to 28% weight loss, potentially rivaling bariatric surgery. Learn about efficacy and safety.
8 min read
Beyond Ozempic: Why Vitamin Sales Soared After GLP-1's Rise
The launch of GLP-1 agonists like Ozempic and Wegovy has not only transformed weight management but also sparked an unexpected trend: a significant increase in vitamin supplement sales. This article delves into the potential reasons behind this phenomenon and what it signifies for individuals managing their health with these powerful medications.
8 min read
Retatrutide's Triumph: Lilly's Triple Agonist Redefines Weight Loss Potential
Eli Lilly's retatrutide is making waves in the weight loss landscape. This comprehensive look delves into its Phase III results, comparing it to existing treatments and exploring its potential impact on obesity management.
6 min read
Celebrity Weight Loss Transformations: Inspiring Journeys & Modern Approaches
Celebrities often inspire us with their dramatic transformations. This article delves into notable celebrity weight loss stories and explores the evolving landscape of weight management, including the role of new medications and personalized health tracking.
8 min read
FDA Warning: How to Spot Fake Tirzepatide and Stay Safe on Weight Loss
The FDA has issued a critical warning regarding counterfeit tirzepatide products. Discover the risks of fake GLP-1 medications and how to verify legitimate sources for your weight loss journey.
6 min read
Reclaiming Your Health: Beyond Weight Loss with GLP-1 Therapies
Explore the profound impact of GLP-1 medications, like semaglutide and tirzepatide, on not just weight management but also on reclaiming one's identity and overall health. Learn how these therapies can be a catalyst for significant life changes, as illustrated by personal journeys.
10 min read
Generic Semaglutide Launches in Canada: What Patients Need to Know
The Canadian market sees the arrival of a generic semaglutide injection, a significant development for individuals managing type 2 diabetes and seeking weight loss solutions. This launch by Dr. Reddy's Laboratories marks a new era of accessibility for this popular GLP-1 therapy.
7 min read
Hims & Hers Downgrade: What It Means for GLP-1 Weight Loss Access
Bank of America cuts Hims & Hers price target as the telehealth giant pivots from compounded GLP-1s to branded alternatives. Here is what this shift means for patients.
8 min read
Oral GLP-1s for Weight Loss Maintenance: A New Frontier
A groundbreaking study reveals that switching to an oral GLP-1 medication like orforglipron can help individuals maintain a significant portion of their weight loss achieved with injectable therapies, offering a new avenue for long-term obesity management.
6 min read
Greg Davies Ozempic Weight Loss: Key Lessons for GLP-1 Users
Comedian Greg Davies reveals the physical and psychological effects of stopping Ozempic after significant weight loss, offering insights for patients on peptide therapy.
6 min read
Beyond 'Ozempic Face': Navigating Skin Changes After Weight Loss
Rapid weight loss, often aided by GLP-1 medications like Ozempic and Mounjaro, can lead to significant physical transformations. While celebrated, these changes can sometimes include unwelcome skin laxity, commonly referred to as 'Ozempic Face.' This article delves into the causes, expert opinions, and potential solutions for this growing concern.
9 min read
Sustainable Weight Loss: Expert Tips for Lasting Results
Achieving sustainable weight loss is a journey, not a race. This comprehensive guide offers expert advice on nutrition, exercise, and mindset to help you build healthy habits for life.
10 min read
Eli Lilly's $4.5 Billion Expansion: Fueling the Future of Weight Loss & Health
Eli Lilly's monumental $4.5 billion investment in its Indiana facilities signals a significant ramp-up in production for groundbreaking GLP-1 agonists like Mounjaro and Zepbound, alongside future weight loss and cardiometabolic disease treatments. This expansion is poised to meet surging global demand and solidify Lilly's position at the forefront of pharmaceutical innovation.
6 min read
GLP-1 Overdose Leads to Severe Diarrhea: A Warning
A man's harrowing experience with extreme diarrhea after overdosing on an experimental GLP-1 drug, retatrutide, serves as a stark reminder of the risks associated with obtaining and using unapproved medications outside of medical supervision. This article delves into the case, the science behind these powerful weight loss drugs, and the importance of regulated healthcare.
7 min read
GLP-1 Pills for Weight Loss: 8 Key Insights Before You Begin
GLP-1 medications are now available as pills for weight loss, offering a needle-free alternative. This comprehensive guide explores what you need to know before starting, including efficacy, absorption, side effects, and lifestyle considerations.
12 min read
GLP-1 Weight Loss Drugs and Hair Loss: What the New Study Reveals
Recent findings suggest a connection between GLP-1 agonists and temporary hair shedding. Discover the science, risk factors, and how to manage this side effect while on weight loss therapy.
6 min read
Ricki Lake's 40lb Weight Loss: A Diet, Fitness, and Self-Tracking Success Story
Ricki Lake shares her successful 40-pound weight loss journey, achieved through a dedicated approach to diet, consistent exercise, and insightful self-monitoring, offering valuable lessons for those seeking sustainable health improvements.
6 min read
GLP-1 Weight Loss Drugs: The Risk of Stopping and Restarting
New research suggests that the effectiveness of popular GLP-1 weight loss medications may significantly diminish with intermittent use. Understand the implications for your health journey.
7 min read
GLP-1s and Hair Loss: Understanding the Link & Treatment Options
The rise of GLP-1 medications for weight loss has brought to light a common side effect: temporary hair thinning. This article delves into why this happens and what you can do about it.
8 min read
GLP-1 Drugs, Body Image, and the Rise of 'Ballerina Boobs'
The rise of GLP-1 medications like Ozempic and Mounjaro has coincided with a notable shift in aesthetic preferences, particularly concerning breast size. This article delves into the potential links, societal pressures, and practical considerations for women navigating these changes.
6 min read
Eli Lilly's Q1 Surge: GLP-1 Success Fuels Strong Outlook
Eli Lilly's first quarter of 2026 saw record-breaking performance, largely propelled by the immense demand for its GLP-1 based therapies, Mounjaro and Zepbound. The pharmaceutical giant not only surpassed financial expectations but also significantly raised its full-year outlook, signaling continued growth and innovation in the metabolic disease space.
7 min read
Semaglutide NAION Risk: New Study Findings for Weight Loss Patients
A recent analysis published in JAMA Ophthalmology reveals a significant increase in NAION risk associated with semaglutide compared to SGLT2 inhibitors, though absolute risk remains low.
8 min read
Tirzepatide Plateaus: Understanding 'Plateau Panic' and What Comes Next
Many individuals experience remarkable initial success with Tirzepatide, only to find their progress unexpectedly stalling. This phenomenon, known as 'Plateau Panic,' is a growing concern. This article delves into why these plateaus occur, what they signify, and the advanced strategies available to help you regain momentum.
8 min read
Beyond the Scale: Navigating Weight Loss and Appearance Concerns
Significant weight loss, often achieved with medications like GLP-1 agonists, can bring about transformative health benefits but also raises questions about changes in appearance. This article delves into the phenomenon of 'Mounjaro face,' discusses how to approach sensitive conversations about appearance with friends and family, and offers practical advice for maintaining well-being during and after weight loss.
9 min read
The 'Ozempic Personality': Understanding Emotional Changes with GLP-1s
While GLP-1 medications are celebrated for weight loss and reduced food noise, some users report emotional flattening. This article delves into the 'Ozempic personality' phenomenon, its potential causes, and expert perspectives on managing these psychological shifts.
7 min read
Athlete's Inspiring Weight Loss: A Journey Back to Health and Sport
Kaitlin Hicks, a former athlete, shares her powerful story of overcoming grief-induced weight gain, her health struggles, and her triumphant return to sport after losing a significant amount of weight.
7 min read
Jelly Roll's 275-lb Loss: Beyond GLP-1s & Ozempic
Country star Jelly Roll has shed an astonishing 275 pounds since 2022, transforming his life without relying on GLP-1 medications like Ozempic, Wegovy, or Mounjaro. His story highlights the power of addressing food addiction through therapy, consistent exercise, and mindful eating—proving that peptide therapy alternatives can yield profound, lasting change.
4 min read
The Risks of Cycling GLP-1s: Why Consistency Matters for Weight Loss
New data shows many patients cycle on and off GLP-1 medications. Discover why this approach may hinder long-term health and why tracking is essential.
3 min read
Duodenal Resurfacing May Prevent Weight Regain After Stopping Ozempic
New research presented at Digestive Disease Week 2026 suggests a minimally invasive 'gut reset' procedure could help patients maintain weight loss after discontinuing GLP-1 medications like Ozempic and Wegovy. The findings address a major challenge in obesity treatment: weight regain after stopping therapy.
7 min read